Supporting the Diagnosis of Fabry Disease Using a Natural Language Processing-Based Approach
Authors:
- Adrian A. MichalskiAMAdrian A. Michalski
- Karol LisKLKarol Lis
- Joanna StankiewiczJSJoanna Stankiewicz
- Sylwester M. KloskaSKSylwester M. Kloska
- Arkadiusz SyczASArkadiusz Sycz
- Marek DudzińskiMDMarek Dudziński
- Katarzyna Muras-SzwedziakKMKatarzyna Muras-Szwedziak
- Michał NowickiMichał Nowicki
- Stanisława Bazan-SochaStanisława Bazan-Socha
- Michal J. DabrowskiMDMichal J. Dabrowski
- Grzegorz W. BasakGBGrzegorz W. Basak
Open Access
- 22 May 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (10) , 3599
Abstract
In clinical practice, the consideration of non-specific symptoms of rare diseases in order to make a correct and timely diagnosis is often challenging. To support physicians, we developed a decision-support scoring system on the basis of retrospective research. Based on the literature and expert knowledge, we identified clinical features typical for Fabry disease (FD). Natural language processing (NLP) was used to evaluate patients’ electronic health records (EHRs) to obtain detailed information about FD-specific patient characteristics. The NLP-determined elements, laboratory test results, and ICD-10 codes were transformed and grouped into pre-defined FD-specific clinical features that were scored in the context of their significance in the FD signs. The sum of clinical feature scores constituted the FD risk score. Then, medical records of patients with the highest FD risk score were reviewed by physicians who decided whether to refer a patient for additional tests or not. One patient who obtained a high-FD risk score was referred for DBS assay and confirmed to have FD. The presented NLP-based, decision-support scoring system achieved AUC of 0.998, which demonstrates that the applied approach enables for accurate identification of FD-suspected patients, with a high discrimination power.Keywords
This publication has 42 references indexed in Scilit:
- Fibrosis: a key feature of Fabry disease with potential therapeutic implicationsOrphanet Journal of Rare Diseases, 2013
- Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brainOrphanet Journal of Rare Diseases, 2013
- Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry diseaseJournal of Medical Genetics, 2012
- Fabry disease: a review of current management strategiesQJM: An International Journal of Medicine, 2010
- Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onsetGLAmutation c.936+919G>A (IVS4+919G>A)Human Mutation, 2009
- Elevated globotriaosylsphingosine is a hallmark of Fabry diseaseProceedings of the National Academy of Sciences, 2008
- High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*The American Journal of Human Genetics, 2006
- Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome SurveyEuropean Journal of Clinical Investigation, 2004
- The Molecular Defect Leading to Fabry Disease: Structure of Human α-GalactosidaseJournal of Molecular Biology, 2004
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous malesJournal of Medical Genetics, 2001